AMN HEALTHCARE INC (AMN)
Health Care · healthcare staffing and services · NYSE
AMN Healthcare provides comprehensive, technology-enabled workforce solutions and staffing services to help healthcare organizations optimize their talent and clinical operations.
What AMN HEALTHCARE INC does
AMN Healthcare provides technology-enabled healthcare workforce solutions and staffing services to a wide range of healthcare organizations. The company offers a comprehensive portfolio including nurse and allied staffing, physician and leadership recruitment, managed services programs, and workforce management technology, helping clients optimize staffing to reduce complexity and increase operational efficiency.
Themes: healthcare staffing, workforce management technology, SaaS for healthcare providers, talent acquisition and RPO, healthcare advisory services
Fundamentals
- Price$35.44 as of 2026-10-08 close
- Market cap$1.4B as of 2026-08-04 (share count; price 2026-10-08)
- 1-year return+83.9% 2025-10-08 close $19.27 → 2026-10-08 close $35.44
- P/E13.22 as of 2026-10-08
- Net margin-3.5% FY2025, SEC XBRL
- Gross margin+28.3% FY2025, SEC XBRL
- ROE-14.9% FY2025, SEC XBRL
- Debt / equity1.00 as of 2026-09-03
- Revenue growth (YoY)+24.0% as of 2026-09-03
- Revenue CAGR (3y)-19.5% SEC XBRL
- Beta0.88 as of 2026-09-03
- Last reported earnings2025-11-06 most recent in our data — SEC EDGAR Form 8-K (Item 2.02); no newer announcement filed
How AMN compares in its sector
- price-to-earnings ratiobottom 25% 185 covered Health Care peers, as of 2026-10-08
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-03
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRbottom 10% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How AMN HEALTHCARE INC looks technically
AMN HEALTHCARE INC (AMN) is trading 36.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 140 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 13, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 4 trading days ago. Trading volume is running unusually high — about 2.1× its 30-day average, a sign of heightened interest.
Trend
8
| Distance from the 200-day | it is trading 36.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +36.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $34.42 | $34.42 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $26.03 | $26.03 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 33.41. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 140 trading days ago — a "golden cross", a bullish long-term signal | 140 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 13, below the 25 that marks a real trend) | 13.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30) | 53.2 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($33.41 to $38.44) — its "stochastic" reading is 40 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 40.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 17 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $38.44 | $38.44 |
|---|---|---|
| From the 52-week high | it is 7.8% below its 52-week high (its highest price of the past year) | -7.8% |
| Above the 52-week low | it is 136.7% above its 52-week low (its lowest price of the past year) | +136.7% |
| Below the 52-week high | it is 7.8% below its highest point of the past year | 7.8% |
| Since a 20-day breakout | it made a new 20-day high about 4 trading days ago | 4 sessions |
| Since a 55-day breakout | it made a new 55-day high about 4 trading days ago | 4 sessions |
| All-time high | its highest closing price on record is $129.12 (set on 2021-12-27) | $129.12 |
| Given back of the 52-week move | over the past year its closes ranged ($15.10 to $36.84), and it has given back only a small part of its rise from last year’s low — 6% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $22.71 to $23.40. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 6.4% |
| From the all-time high | it is 72.6% below its all-time high | -72.5% |
| Nearest price level | it is trading 0.6% below a resistance level at $35.66 — a price it turned at four times since 2026-07-17, most recently on 2026-09-16. Since 2024-10-08 it has 14 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.6% |
| All-time low | its lowest closing price on record is $3.60 (set on 2011-10-04) | $3.60 |
| Above the all-time low | it is 884.4% above its all-time low | +884.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 76% of it) | 24th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.29 between its high and its low — about 3.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.29 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $32.97 and $37.06 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $32.97 – $35.02 – $37.06 |
| Typical daily range (% of price) | its price moves about 3.6% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.6% |
| Stretch from the 200-day average | it is trading 7.3 daily ranges above its 200-day average price (36.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 2.1× its 30-day average, a sign of heightened interest | 2.15× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 8 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 8 sessions ago |
|---|---|---|
| Since a bullish engulfing | 7 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 7 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 1.1% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -1.1% |
|---|---|---|
| Open gap | it gapped 2.8% above the previous close 43 sessions ago and has not traded back through the level it left behind at 30.8 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.8% |
| Gap filled | a 3.6% gap up opened on 2026-07-22 has been "filled" 55 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 55 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -3.8% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 4.0 percentage points (the stock gained 5.1% while the market gained 1.0%) | +4.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 6.6 percentage points (the stock gained 10.5% while the market gained 3.8%) | +6.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 73.5 percentage points (the stock gained 90.9% while the market gained 17.5%) | +73.5% |
| vs market, 12 months | over the past 12 months this stock beat the market by 68.9 percentage points (the stock gained 83.9% while the market gained 15.0%) | +68.9% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 4.3% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 1.0% of the share price, which is taken to mean a barrier that gives way easily. | +4.3% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 39% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $25.52 — a volume-weighted average of daily closes over 189 sessions, not a true tick-by-tick VWAP. | +38.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-08-07 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $34.70 — a volume-weighted average of daily closes over 44 sessions, not a true tick-by-tick VWAP. | +2.1% |
Price levels it has turned at before
AMN last closed at $35.44 on 2026-10-08. Since 2024-10-08 it has turned at 14 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $35.66 | Resistance | 0.6% above the last close | turned there four times · 2026-07-17 to 2026-09-16 |
| $33.27 | Support | 6.1% below the last close | turned there twice · 2026-06-17 to 2026-09-24 |
| $31.84 | Support | 10.2% below the last close | turned there twice · 2026-05-11 to 2026-09-03 |
| $30.20 | Support | 14.8% below the last close | turned there four times · 2024-12-04 to 2026-08-06 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $33.41.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
This reading has stood for 6 trading days, since 2026-10-01.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Unusually heavy trading volume · trendless / choppy (low ADX) · beating the market · Stretched far above its 200-day average (6+ daily ranges) · Trading above the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · breakout · volume and relative volume
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.56 mean, 1=Strong Buy…5=Strong Sell) — 7 analysts
- Mean price target$36.14 range $28.00 – $40.00; median $36.00
Analyst estimates, as of 2026-10-04. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for AMN
- Consensus EPS estimate$0.2286 next reporting period, as of 2026-10-04
- Estimate change, 30 days$0.00 (0.0%) from $0.2286, on 2026-08-31, 34-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on healthcare provider demand for temporary staffing and recruitment services.","Operational and financial unpredictability associated with labor disruption events.","Intense competition within the healthcare staffing and workforce technology sectors."]
What changed in the latest 10-Q
AI-assisted comparison of AMN's 10-Q filed 2026-08-07 against the prior one filed 2026-05-08.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-07) states for the three months ended June 30, 2026, revenue was $673.2 million compared to $658.2 million for the same period last year.
- Newer filing (2026-08-07) states for the six months ended June 30, 2026, revenue was $2,051.6 million compared to $1,347.7 million for the same period last year.
- Newer filing (2026-08-07) states nurse and allied solutions segment revenue comprised 76% and 59% of total consolidated revenue for the six months ended June 30, 2026 and 2025, respectively.
- Newer filing (2026-08-07) states physician and leadership solutions segment revenue comprised 16% and 26% of total consolidated revenue for the six months ended June 30, 2026 and 2025, respectively.
- Newer filing (2026-08-07) states technology and workforce solutions segment revenue comprised 8% and 15% of total consolidated revenue for the six months ended June 30, 2026 and 2025, respectively.
- Newer filing (2026-08-07) states demand for travel nurses increased compared to the prior quarter and prior year along with increases in the percentage of orders filled.
- Newer filing (2026-08-07) states the international nurse business continued its sequential growth and year-over-year growth in the second quarter with strong traveler and direct placement growth.
- Newer filing (2026-08-07) states demand for locum tenens staffing business in the second quarter increased from prior year and prior quarter.
- Newer filing (2026-08-07) states days filled were lower compared to prior year but up slightly sequentially.
- Newer filing (2026-08-07) states revenue per day filled was in line with prior year but was down sequentially.
- Removed:
- Older filing (2026-05-08) stated for the three months ended March 31, 2026, revenue was $1,378.4 million compared to $689.5 million for the same period last year.
- Older filing (2026-05-08) stated nurse and allied solutions segment revenue comprised 82% and 60% of total consolidated revenue for the three months ended March 31, 2026 and 2025, respectively.
- Older filing (2026-05-08) stated physician and leadership solutions segment revenue comprised 12% and 25% of total consolidated revenue for the three months ended March 31, 2026 and 2025, respectively.
- Older filing (2026-05-08) stated technology and workforce solutions segment revenue comprised 6% and 15% of total consolidated revenue for the three months ended March 31, 2026 and 2025, respectively.
- Older filing (2026-05-08) stated during the first quarter, the nurse and allied solutions segment experienced substantial labor disruption staffing activity and supplied thousands of clinicians for multiple simultaneous large scale labor disruption events.
- Older filing (2026-05-08) stated investments in technology and processes over several years enabled the Company to effectively meet client needs throughout extended events during the quarter.
- Older filing (2026-05-08) stated while demand for travel nurses decreased compared to the prior year, the percentage of orders filled increased, and traveler volume was higher than prior year.
- Older filing (2026-05-08) stated the international nurse business continued its sequential growth in the first quarter with recent visa bulletins increasing the number of visa-eligible candidates to be placed.
- Older filing (2026-05-08) stated allied staffing experienced sequential increases in demand during the first quarter, consistent with the previous year, with volume demonstrating growth both sequentially and year over year.
- Older filing (2026-05-08) stated demand for the locum tenens staffing business in the first quarter increased slightly from prior year but decreased sequentially.
- Older filing (2026-05-08) stated revenue per day filled increased in the first quarter as compared to the prior year but was down sequentially.
- Reworded:
- Revenue reporting period changed from three months ended March 31, 2026 in the older filing to three months and six months ended June 30, 2026 in the newer filing.
- Segment revenue percentage reporting period changed from three months ended March 31, 2026 and 2025 in the older filing to six months ended June 30, 2026 and 2025 in the newer filing.
- Travel nurse division description changed from 'also affected by these labor disruptions, resulting in heightened demand for rapid response nurses at elevated bill rates' in the older filing to 'also was impacted by the labor disruption events, with heightened demand for rapid response nurses at elevated bill rates in the first quarter. While labor disruption and travel nurse revenue was lower sequentially in the second quarter' in the newer filing.
- Travel nurse demand description changed from 'decreased compared to the prior year' in the older filing to 'increased compared to the prior quarter and prior year' in the newer filing.
- Allied staffing description changed from 'consistent with the previous year, with volume demonstrating growth both sequentially and year over year' in the older filing to 'with volume demonstrating strong year-over-year growth' in the newer filing.
- Locum tenens demand description changed from 'increased slightly from prior year but decreased sequentially' in the older filing to 'increased from prior year and prior quarter' in the newer filing.
- Notes:
- Newer filing text appears truncated at the end of the Recent Trends section, mid-sentence, potentially omitting additional content.
- Only the provided excerpts of the MD&A sections were compared; other portions of the filings were not available in the source texts.
Risk Factors
- Added:
- The filing dated 2026-08-07 states that during the three months ended June 30, 2026, none of the Company's directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement.
- The filing dated 2026-08-07 includes a table of monthly share repurchase activity for the six months ended June 30, 2026.
- The filing dated 2026-08-07 discloses that during the six months ended June 30, 2026, the Company repurchased approximately 85 thousand shares of common stock at an average price of $26.33 per share, for an aggregate purchase price of $2.3 million excluding excise taxes.
- The filing dated 2026-08-07 states that $224.4 million remained under the Company Repurchase Program as of June 30, 2026.
- The filing dated 2026-08-07 includes cover page reference for the quarterly period ended June 30, 2026 in the exhibit description for Exhibit 104.
- Removed:
- The filing dated 2026-05-08 disclosed that the Foletta Family Trust dated January 30, 2015 entered into a Rule 10b5-1 trading arrangement on March 12, 2026 providing for the sale of up to 3,681 shares of the Company's common stock, with termination on March 13, 2027, and that Mark Foletta, a member of the Board of Directors, is a trustee of the Foletta Family Trust.
- The filing dated 2026-05-08 stated that $226.7 million remained as of March 31, 2026 under the Company Repurchase Program.
- The filing dated 2026-05-08 stated that during the three months ended March 31, 2026, the Company did not repurchase any shares of common stock.
- The filing dated 2026-05-08 included Exhibit 4.1 'Description of Securities' in the exhibit list.
- The filing dated 2026-05-08 included cover page reference for the quarterly period ended March 31, 2026 in the exhibit description for Exhibit 104.
- Reworded:
- The newer filing dated 2026-08-07 updates the remaining authorization amount under the Company Repurchase Program from $226.7 million as of March 31, 2026 to $224.4 million as of June 30, 2026.
- The newer filing dated 2026-08-07 changes the repurchase discussion period from three months ended March 31, 2026 to six months ended June 30, 2026.
- The newer filing dated 2026-08-07 replaces the disclosure about the Foletta Family Trust Rule 10b5-1 trading arrangement with a statement that no directors or officers adopted, modified or terminated any Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the three months ended June 30, 2026.
- The newer filing dated 2026-08-07 omits Exhibit 4.1 'Description of Securities' from the exhibit list.
- The signature dates changed from May 7, 2026 to August 6, 2026.
- Notes:
- The provided texts include the full Part II Items 2 through 6, not only the Risk Factors section; the Risk Factors section itself (Item 1A) appears unchanged.
- This comparison is based solely on the provided text excerpts, which may not include the complete filings.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 2 sells ($114362) — 1 selling insider
Most recent open-market transaction: 2026-06-15. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about AMN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding AMN as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 10,542,766
- Reported value $341,269,340
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about AMN's institutional holders → See what each manager we track holds →
Short interest (FINRA)
AMN had 3,488,132 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
AMN had 9.01% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.91 days to cover at the same settlement.
- Reported short interest (shares) 3,488,132
- Short interest (% of shares outstanding) 9.01%
- Prior settlement (shares) 3,419,996
- Reported change 1.99%
- Days to cover (reported) 5.91
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Cross Country Healthcare (CCRN)
- HealthStream (HSTM)
- Korn Ferry (KFY)
- Heidrick & Struggles (HSII)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare AMN vs…
Frequently asked questions
What does AMN HEALTHCARE INC (AMN) do?
AMN Healthcare provides technology-enabled healthcare workforce solutions and staffing services to a wide range of healthcare organizations. The company offers a comprehensive portfolio including nurse and allied staffing, physician and leadership recruitment, managed services programs, and workforce management technology, helping clients optimize staffing to reduce complexity and increase operational efficiency.
What sector is AMN HEALTHCARE INC (AMN) in?
AMN HEALTHCARE INC (AMN) is classified in the Health Care sector. Its industry is healthcare staffing and services. It trades on NYSE.
Who are AMN HEALTHCARE INC's (AMN) competitors?
Notable peers of AMN HEALTHCARE INC (AMN) include Cross Country Healthcare, HealthStream, Korn Ferry and Heidrick & Struggles. This peer set is informational only — not financial advice.
Is AMN HEALTHCARE INC (AMN) overbought or oversold right now?
AMN HEALTHCARE INC (AMN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 53, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on AMN come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.